Stemina Biomarker Discovery
Business Services · Wisconsin, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
504 S Rosa Rd Ste 150, Madison, Wisconsi...Phone Number
(608) 204-0104Website
www.stemina.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Stemina Biomarker Discovery
Stemina Biomarker Discovery specializes in in vitro toxicity testing for drugs, food, and consumer products, providing alternatives to animal testing through human cell-based assays. Their services include the devTOX Predict and Cardio Predict assays, which predict developmental and cardiotoxicity, respectively, using advanced metabolomics profiling. The company aims to support toxicologists and improve human health by delivering timely, high-quality data at a fraction of the cost of traditional methods. Additionally, Stemina is involved in the diagnosis and treatment of neurological disorders, particularly through their NeuroPointDX division focused on autism spectrum disorder.Explore more
Stemina Biomarker Discovery Org Chart
MS
Avalyn Pharmaceuticals Senior VP & Chief Fina...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stemina Biomarker Discovery your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Stemina Biomarker Discovery had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Stemina Biomarker Discovery recently announced quarterly report
Stemina Biomarker Discovery, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Stemina Biomarker Discovery
Funding: Get notified immidiatlly once Stemina Biomarker Discovery has new funding data
Product Launch: Get notified when Stemina Biomarker Discovery launches new products
Check if Stemina Biomarker Discovery has recently received funding, and reach out quickly before it becomes old news!
Check out if Stemina Biomarker Discovery is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Stemina Biomarker Discovery
Compare insights from companies similar to Stemina Biomarker Discovery, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Stemina Biomarker Discove...
$5.9M
11-50
Private
$16.9M
2006
RB
Robert BurrierChief Operating Officer & & Development Vice President, Research
Company Profile Activity
Activity Insights
Stemina Biomarker Discovery is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Stemina Biomarker Discovery is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Stemina Biomarker Discovery.
Stemina Biomarker Discovery financials insights
Gather financial insights about Stemina Biomarker Discovery, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$4.3M
2015
Grant
$2.7M
Private Equity
$8.4M
2016
Debt
$1M
2020
Debt
$350K
2021
Debt
$205K
Stemina Biomarker Discovery Tech Stack
A closer look at the technologies used by Stemina Biomarker Discovery
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Stemina Biomarker Discovery has received an SBA PPP loan in the amount of $205,299 from First Business Bank resulting in the retention of 8 jobs.
Funding
Stemina Biomarker Discovery has received an SBA PPP loan for $350,000-1 million from First Business Bank, supporting the retention of 12 jobs.
Funding
Stemina Biomarker Discovery News & Media
Stemina’s Human Cell-Based devTOX quickPredict Assay Able to Predict Developmental Toxicity Potential of Nicotine-Containing Products
MADISON, Wis.--(BUSINESS WIRE)-- #Replace_animal_testing--Research shows that Stemina’s human cell-based devTOX quickPredict assay can predict developmental toxicity potential of nicotine-containing productsNeuroPointDX Names Two Senior Diagnostics Industry Executives to the Board of Directors
MADISON, Wis.--(BUSINESS WIRE)--NeuroPointDX, a division of Stemina Biomarker Discovery, today announced the appointment of two new board members with extensive experience in the development and commercialization of new molecular diagnostic tests. Barbara Handelin, PhD was founding Director of the DNA Diagnostics Lab at Integrated Genetics (acquired by LabCorp @ $925M), and Tony Shuber was Chief Technology Officer and cofounder of Exact Science Corporation and Predictive Biosciences. The appoinNeuroPointDX Names Two Senior Diagnostics Industry Executives to the Board of Directors
NeuroPointDX, a division of Stemina Biomarker Discovery, today announced the appointment of two new board members with extensive experience in the devStemina’s Human Stem Cell-Based Test Demonstrates Potential to Predict Which Drugs and Chemicals Cause Birth Defects
MADISON, Wis.--(BUSINESS WIRE)-- #EPA--Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stemina Biomarker Discovery
Sign Up For FreeTo access detailed company insights
Stemina Biomarker Discovery specializes in in vitro toxicity testing for drugs, food, and consumer products, providing alternatives to animal testing through human cell-based assays. Their services include the devTOX Predict and Cardio Predict assays, which predict developmental and cardiotoxicity, respectively, using advanced metabolomics profilin... Read More
